Ansell Limited (ASX:ANN)

Market Cap	6.26B +34.2%
Revenue (ttm)	3.09B +6.8%
Net Income	301.53M +105.3%
EPS	2.10 +108.8%
Shares Out	138.78M
PE Ratio	21.52
Forward PE	19.18
Dividend	0.97 (2.15%)
Ex-Dividend Date	Aug 31, 2026

Volume	575,307
Open	45.44
Previous Close	45.10
Day's Range	44.89 - 45.66
52-Week Range	25.05 - 45.90
Beta	0.55
Analysts	Hold
Price Target	39.95 (-11.5%)
Earnings Date	Feb 21, 2027

About Ansell

Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, operating room consumables, single-use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veter...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1893
• Employees: 15,000
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ANN

Financial Performance

In fiscal year 2026, Ansell's revenue was $2.14 billion, an increase of 6.83% compared to the previous year's $2.00 billion. Earnings were $208.60 million, an increase of 105.31%.

Financial numbers in USD

Analyst Summary

According to 11 analysts, the average rating for ANN stock is "Hold." The 12-month stock price target is $39.95, which is a decrease of -11.50% from the latest price.

Price Target

$39.95

(-11.50% downside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 9, 2026

Data Sources Report a data error